Drugmaker Sues F.D.A. Over Right to Discuss Off-Label Uses

Amarin Pharma says it has a constitutional right to share information on unapproved uses of its products, a practice the government frowns on.









from NYT > Health http://ift.tt/1cda6HQ
via health&fitness